Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-952-9 | CAS number: 5577-13-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP. Guideline study
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Ethyl [(4-methylphenyl)sulphonyl]carbamate
- EC Number:
- 226-952-9
- EC Name:
- Ethyl [(4-methylphenyl)sulphonyl]carbamate
- Cas Number:
- 5577-13-9
- Molecular formula:
- C10H13NO4S
- IUPAC Name:
- ethyl [(4-methylphenyl)sulfonyl]carbamate
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J mice
- Sex:
- female
Study design: in vivo (LLNA)
- No. of animals per dose:
- 20 females (5 females per group)
Group 1: 0% w/w
Group 2: 20% w/w
Group 3: 40% w/w
Group 4: 80% w/w
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- other: Number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes
- Variability:
- Range 0-5
- Test group / Remarks:
- Male
- Remarks on result:
- other: Number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes was determined see explanation below
- Remarks:
- Number of micronucleated polychromatic erythrocytes per 2000 polychromatic erythrocytes males Range 0 - 5 Mean 1.2 SD 1.2 n 180 SD = Standard deviation n = Number of observations Since there were no substantial differences between sexes in toxicity only male animals were used in the main study. Five male animals were used in each treatment group. The mean number of micronucleated polychromatic erythrocytes scored in Tolfamato treated groups were compared with the corresponding vehicle control group. All animals treated with Tolfamato exhibited both group mean and individual micronucleated polychromatic erythrocytes frequencies which were comparable with both the concurrent vehicle control and the laboratory’s historical vehicle control data for both time points. The groups that were treated with Tolfamato showed no decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the concurrent vehicle control group, indicating a lack of toxic effects of this test substance on erythropoiesis. The groups that were treated with cyclophosphamide showed an expected decrease in the ratio of polychromatic to normochromatic erythrocytes compared to the vehicle controls, demonstrating toxic effects on erythropoiesis.
- Key result
- Parameter:
- other: Mortality and toxic signs
- Remarks on result:
- other: Mortality and toxic signs was observed. See explanation below
- Remarks:
- The animals of the group treated with 375 mg Tolfamato/kg body weight and the animals of the negative and positive control groups showed no treatment related clinical signs of toxicity or mortality. The following clinical observations were made in the groups treated with 1500 and 750 mg Tolfamato/kg body weight: During the first hour after dosing 4 animals of the groups treated with 1500 mg/kg body weight were lethargic, 3 of them also showed ataxia and the fourth animal also showed ventral recumbency. All other animals treated with 1500 mg/kg body weight and the animals treated with 750 mg/kg body weight showed no reaction to treatment. Within 2 hours after dosing 6 animals of the groups treated with 1500 mg/kg body weight and 1 animal treated with 750 mg/kg body weight showed the following toxic signs: lethargy, rough coat and hunched posture. One animal treated with 1500 mg/kg body weight had a rough coat. Within 19 hours after dosing all animals had recovered from the treatment except for one animal treated with 1500 mg/kg body weight which still showed the following toxic signs: lethargy, rough coat and hunched posture. The animal recovered from the treatment within 43 hours after dosing.
Any other information on results incl. tables
Skin reactions/irritation: no irritaion of the ears was observed in any of the animals examined.
Systemic toxicity: body weights and body weight gains of experimental animals remained in the same range as controls over the study period. The body weight loss noted for some animales across the dose gropus was considered not toxicologically significant since the changes were slight in nature and no concentration-related incidence was apparent.
Macroscopy of the auricular lymph nodes and surrounding area: All auricular lymph nodes were normal in size and no macroscopic abnormalities of the surrounding area were noted in any of the animals.
Readioactivity measurements: Mean DPM/animal values for the experimental groups treated with test substance concentrations 20, 40 and 80% were 323,253 and 305 DPM respectively. The mean DPM/animal value for the vehicle control group was 437 DPM.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not induce delayed contact hypersensivity in the murine LLNA. For more information, see Executive summary.
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- Tolfamato would not be regarded as a skin sensitizer according to the recommendations made in the test guidelines. The test substance does not has to be classified and has no obligatory labelling requirement for sensitization by skin contact.
- Executive summary:
Interpretation of results:
Not induce delayed contact hypersensivity in the murine LLNA. Mean DPM/animal values for the experimental grous treated with test substance concentration 20, 40 an 80% were 323, 253 and 305 DPM respectively. The mean DPM/animal value for the vehicule control group was 437 DPM.
The SI values calculated for the substance concentrations 20, 40 an 80% were 0.7, 0.6 and 0.7 respectively.
Since there was no indication that the test substance elicits an SI >= 3 when teste up to 80%. TOLFAMATO was considered not to be a skin sensitizer. It was established that the EC3 value (the estimated test substance concentration that will give a SI=3) (If any) exceeds 80%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.